Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Inflammation × Ketorolac × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Obesity 1 Kidney Neoplasms 1 Inflammation 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

XENP 1595 2 salicylsalicylic acid 1 microcrystalline cellulose 1 ginger extract 1 epigallocatechin gallate 1 dapagliflozin 1 Tablets 1 Sulindac 1 Specimen Handling 1 Sodium Salicylate 1 Radiotherapy, Conformal 1 Pregabalin 1 Omeprazole 1 Losartan 1 Ketorolac 1 Interleukin 1 Receptor Antagonist Protein 1 Infliximab 1 Etanercept 1 Atorvastatin 1 Ascorbic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06150898 2025-06-13

KePreSt

Jules Bordet Institute

Phase 2 Recruiting

Breast Neoplasms, Inflammation, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡